TScan Therapeutics Reports Second Quarter 2022 Financial Results and Highlights Recent Progress October 14, 2022
TScan Therapeutics Reports Second Quarter 2022 Financial Results and Highlights Recent Progress August 11, 2022
TScan Therapeutics Announces Publication in Cell Highlighting the Discovery of Tumor Antigens and TCRs for the Treatment of Solid Tumors Using Foundational Screening Technology July 11, 2022
TScan Therapeutics Announces FDA Clearance of Investigational New Drug Application for TSC-101 for the Treatment of Hematologic Malignancies May 31, 2022
TScan Therapeutics Reports First Quarter 2022 Financial Results and Upcoming Anticipated Milestones May 10, 2022
TScan Therapeutics Reports Full Year 2021 Financial Results and Highlights Key 2022 Priorities March 11, 2022
